Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile
Transplant Immunotherapy Program Los Angeles

@tiplosangeles

Expert Team Specializing in #Transplantation, #Immunotherapy, and Clinical Research. Led by Dr. Stanley Jordan, MD and Dr. Ashley Vo. #TIP @stanleycjordan2

ID: 979911873767251968

calendar_today31-03-2018 02:42:51

279 Tweet

361 Followers

407 Following

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Sharing Dr Heeger and Dr Jordan's extensive review, "Translating B cell immunology to the treatment of antibody-mediated allograft rejection" now published in Nature Reviews Nephrology! 📃 Available at: nature.com/articles/s4158… #transplant #transplantation #Immunology

Sharing Dr Heeger and Dr Jordan's extensive review, "Translating B cell immunology to the treatment of antibody-mediated allograft rejection" now published in <a href="/NatRevNeph/">Nature Reviews Nephrology</a>! 📃 Available at: nature.com/articles/s4158… #transplant #transplantation #Immunology
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Jordan's article, "Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS-CoV-2 infections in solid organ #transplant recipients" is online now! Honored to be featured on the cover of TransplantID Journal! Access it here📰↘️ onlinelibrary.wiley.com/doi/10.1111/ti…

Dr Jordan's article, "Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS-CoV-2 infections in solid organ #transplant recipients" is online now! Honored to be featured on the cover of <a href="/TheTxIDjournal/">TransplantID Journal</a>! Access it here📰↘️ onlinelibrary.wiley.com/doi/10.1111/ti…
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Zhang and Dr Jordan's "Assessment of IgM DSAs in Transplant Recipients: Relationship to De Novo IgG #DSAs and Risk for Antibody Rejection" is available in TransplantDirect! ➡️Access their evaluation of IgM DSAs an an early indicator before dnDSAs at: pubmed.ncbi.nlm.nih.gov/38380350/

Dr Zhang and Dr Jordan's "Assessment of IgM DSAs in Transplant Recipients: Relationship to De Novo IgG #DSAs and Risk for Antibody Rejection" is available in <a href="/TXPDirect/">TransplantDirect</a>! ➡️Access their evaluation of IgM DSAs an an early indicator before dnDSAs at: pubmed.ncbi.nlm.nih.gov/38380350/
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

We are excited to see Dr Kumar's work on dynamic SOX9 published in Science Magazine! "SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian #kidneys" is now available at: tinyurl.com/yc3cczn5

We are excited to see Dr Kumar's work on dynamic SOX9 published in <a href="/ScienceMagazine/">Science Magazine</a>! "SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian #kidneys" is now available at: tinyurl.com/yc3cczn5
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Join our team for several oral abstract sessions today at the AmericanTransplantCongress! Our first is Dr Peter Heeger, 📆6/2 at 3:20 pm, "Utility of Donor-Derived Cell-Free DNA Monitoring for Rejection in the CTOT19 Cohort" 📊 Nutter Theater, Level 1 (114) #ATC2024Philly

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Join Dr Steven Wisel for his oral abstract today at the AmericanTransplantCongress! 📆6/2 at 3:40 pm, "Nationwide Use of Machine Perfusion Demonstrates Increased Organ Utilization and Improved DCD Graft Survival in #Liver #Transplantation" 📍204-ABC, Level 2 #ATC2024Philly

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Lastly today at the AmericanTransplantCongress 📆6/2 at 4:50 pm, join David Thomas presenting "Nanostring Assessment of #Kidney Transplant Biopsies Using the Banff Human Organ Transplant (BHOT) Panel Effectively Distinguishes between AMR and Non-AMR Conditions" 📍107-AB, Level 1 #ATC2024Philly

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Tomorrow, 📆6/3 at AmericanTransplantCongress, join Dr Edmund Huang presenting an oral abstract at 3 pm ➡️ "Tissue Gene Expression Suggests Alternative Mechanisms of Injury in Chronic Active T-cell Mediated Rejection"! 📈We hope to see you there! 📍108-AB, Level 1 #ATC2024Philly

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Edmund Huang will be presenting his IIT results at the AmericanTransplantCongress, Tues 6/4 at 1:30 pm "Comparison of Tacrolimus Extended-Release (#Envarsus XR) to Tacrolimus Immediate- Release in HLA Sensitized #Kidney Transplant Recipients (NCT04225988) #ATC2024Philly 📍115-ABC, Level 1

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Ashley Vo will be at the AmericanTransplantCongress Poster Session: #Kidney IS Desensitization starting soon! 6/4 at 9:15- 10 am. Please stop by to discuss her posters on 5 Year #Clazakizumab Data and Impact of AT1R antibody on allograft outcomes! #ATC2024Philly 📍Exhibit Hall A, Level 2

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Our final oral abstract AmericanTransplantCongress will be presented by Dr Stan Jordan on 6/5 at 10:20 am during the Oral Abstract Session: Kidney IS Novel Regimens! ➡️Please join him for "CTLA-4Ig + Anti-IL6/IL6R in Long-Term Rejection-Free Graft Survival" 📊#ATC2024Philly 📍107-AB, Level 1

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Ashley Vo and Dr Stan Jordan will both present at the AmericanTransplantCongress Oral Abstract Session #Kidney Immunosuppression: #Desensitization on 6/5! Presenting at 9:30 on Daratumumab and 9:40 am on Imlifidase 5 year analysis! Hope to see you there! #ATC2024Philly 📍108-AB, Level 1

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

We are excited to see Dr Sanjeev Kumar presenting the American Society of Nephrology AKINow Journal Club! June 20th, at 12 pm EDT, featuring his Science Magazine article "SOX9 Switch Links Regeneration to Fibrosis at the Single-Cell Level in Mammalian #Kidneys" Register at: asn-online.org/AKINowJournalC…

We are excited to see Dr Sanjeev Kumar presenting the <a href="/ASNKidney/">American Society of Nephrology</a> AKINow Journal Club! June 20th, at 12 pm EDT, featuring his <a href="/ScienceMagazine/">Science Magazine</a> article "SOX9 Switch Links Regeneration to Fibrosis at the Single-Cell Level in Mammalian #Kidneys" Register at: asn-online.org/AKINowJournalC…
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Excited to share these study results published in Clinical Transplantation "A Randomized Trial Comparing Imlifidase to Plasmapheresis in #Kidney #Transplant Recipients With Antibody-Mediated Rejection"! Available at: onlinelibrary.wiley.com/doi/10.1111/ct…

Excited to share these study results published in <a href="/CliniTransplant/">Clinical Transplantation</a> "A Randomized Trial Comparing Imlifidase to Plasmapheresis in #Kidney #Transplant Recipients With Antibody-Mediated Rejection"! Available at: onlinelibrary.wiley.com/doi/10.1111/ct…
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

Dr Jordan's "Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts" is now available in Transplantation! Go to pubmed.ncbi.nlm.nih.gov/39279047/ for more!

Dr Jordan's "Anti-CD38 Monoclonals for Treatment of
Antibody-mediated Rejection in Renal Allografts" is  now available in <a href="/TransplantJrnl/">Transplantation</a>! Go to pubmed.ncbi.nlm.nih.gov/39279047/ for more!
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

We were excited to see our Case Report "An Unusual Presentation of Bullous Skin Lesions During Pregnancy" published in the Journal of Investigative Medicine High Impact Case Reports. Available at: journals.sagepub.com/doi/10.1177/23… #casereport

Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

We are delighted to see our publication "Tocilizumab (Actemra) Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney #Transplantation" in TransplantDirect! Available at: pmc.ncbi.nlm.nih.gov/articles/PMC12…

We are delighted to see our publication "Tocilizumab (Actemra) Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney #Transplantation" in <a href="/TXPDirect/">TransplantDirect</a>! Available at: pmc.ncbi.nlm.nih.gov/articles/PMC12…
Transplant Immunotherapy Program Los Angeles (@tiplosangeles) 's Twitter Profile Photo

We are extremely excited to see our "Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients" published in Transplant International! Available at: doi.org/10.3389/ti.202…

We are extremely excited to see our "Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients" published in <a href="/Transpl_Int/">Transplant International</a>! Available at: doi.org/10.3389/ti.202…